Tenaya Therapeutics is trading 5.02% up at $0.42, with no confirmed company-specific announcement or catalyst identified for the gain. - The reported price context shows a steep 25.05% decline on October 14. - A preliminary proxy filed October 13 proposed a 1-for-10 to 1-for-25 reverse split; coverage linked it to the prior session’s sell-off, not the current rebound. - The Nasdaq is down 1.07%, leaving the gain against broader market pressure.